The Covid-19 vaccine production club : will value chains temper nationalism?

Simple item page
dc.contributor.authorEVENETT, Simon
dc.contributor.authorHOEKMAN, Bernard M.
dc.contributor.authorROCHA, Nadia
dc.contributor.authorRUTA, Michele
dc.date.accessioned2021-03-05T12:52:32Z
dc.date.available2021-03-05T12:52:32Z
dc.date.issued2021
dc.description.abstractIn the first two months of 2021, the production of COVID-19 vaccines has suffered setbacks delaying the implementation of national inoculation strategies. These delays have revealed the concentration of vaccine manufacture in a small club of producer nations, which in turn has implications for the degree to which cross-border value chains can deter more aggressive forms of Vaccine Nationalism, such as export curbs. This paper documents the existence of this club, taking account of not just the production of final vaccines but also the ingredients of and items needed to manufacture and distribute COVID-19 vaccines. During 2017-19, vaccine producing nations sourced 88% of their key vaccine ingredients from other vaccine producing trading partners. Combined with the growing number of mutations of COVID-19 and the realization that this coronavirus is likely to become a permanent endemic global health threat, this finding calls for a rethink of the policy calculus towards ramping up the production and distribution of COVID-19 vaccines, its ingredients, and the various items needed to deliver them. The more approved vaccines that are safely produced, the smaller will be the temptation to succumb to zero-sum Vaccine Nationalism.en
dc.format.mimetypeapplication/pdfen
dc.identifier.issn1028-3625
dc.identifier.urihttps://hdl.handle.net/1814/70363
dc.language.isoenen
dc.orcid.uploadtrue*
dc.publisherEuropean University Instituteen
dc.relation.ispartofseriesEUI RSCen
dc.relation.ispartofseries2021/36en
dc.relation.ispartofseriesGlobal Governance Programme-441en
dc.relation.ispartofseries[Global Economics]en
dc.rightsinfo:eu-repo/semantics/openAccessen
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCOVID-19en
dc.subjectVaccinesen
dc.subjectValue chainsen
dc.subjectVaccine nationalismen
dc.subjectTrade policyen
dc.subjectExport restrictionsen
dc.subjectmRNAen
dc.subjectLipidsen
dc.subjectNitrile glovesen
dc.subjectSyringesen
dc.subjectVialsen
dc.subject.otherTrade, investment and international cooperationen
dc.titleThe Covid-19 vaccine production club : will value chains temper nationalism?en
dc.typeWorking Paperen
dspace.entity.typePublication
person.identifier.orcid0000-0002-6839-7142
person.identifier.other36413
relation.isAuthorOfPublicationaa98bfa2-ebb3-42d2-85b0-6f57785eb1aa
relation.isAuthorOfPublication.latestForDiscoveryaa98bfa2-ebb3-42d2-85b0-6f57785eb1aa
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
RSC 2021_36.pdf
Size:
1.85 MB
Format:
Adobe Portable Document Format
Description:
Full-text in Open Access
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
3.83 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
RSC Working Papers
COVID-19 Pandemic